← Evidence map

TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER Trials.

Sai-Wei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papercites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 41791006